| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5658079 | Gastroenterología y Hepatología | 2016 | 6 Pages |
Abstract
In conclusion, pentoxifylline has no clear beneficial effects in severe AH but could perhaps be used in patients with a contraindication to corticosteroids. However, the recommendations of clinical guidelines should be reconsidered and it is essential to search for new therapeutic targets for this disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Juan Caballeria,